Paresh Vyas

45.4k citations

235 papers · 9.5k · 2 hit papers · h-index 52

Impact in

Hematology top 0.05%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Genetics top 0.2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

Hematology 175
- Acute Myeloid Leukemia Research 147
- Chronic Myeloid Leukemia Treatments 32
- Multiple Myeloma Research and Treatments 22
Molecular Biology 86
- Epigenetics and DNA Methylation 22
- Protein Degradation and Inhibitors 19

Co-authors: Stuart H. Orkin (7 shared papers)Charles Craddock (23 shared papers)Catherine Porcher (18 shared papers)Irene Roberts (19 shared papers)Ramesh A. Shivdasani (4 shared papers)Ravindra Majeti (8 shared papers)Carl W. Jackson (2 shared papers)Kenneth A. Ault (2 shared papers)
Journals: Blood (75 papers)Journal of Clinical Oncology (16 papers)British Journal of Haematology (10 papers)Haematologica (7 papers)HemaSphere (6 papers)
Partner nations: United Kingdom United States Germany

In The Last Decade

Paresh Vyas

230 papers receiving 9.4k citations

Paresh Vyas's Hit Papers

align trajectories log scale

Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia 2012 · 525 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 Science Translational Medicine
2001 The Lancet Oncology

Peers

Countries citing papers authored by Paresh Vyas

Since Specialization

Citations

This map shows the geographic impact of Paresh Vyas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paresh Vyas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paresh Vyas more than expected).

Fields of papers citing papers by Paresh Vyas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paresh Vyas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paresh Vyas. The network helps show where Paresh Vyas may publish in the future.

Co-authors

The 25 scholars most cited alongside Paresh Vyas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paresh Vyas Line = papers co-authored together Paresh Vyas links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 235 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Pathology and genetics: Tumours of haematopoietic and lymphoid tissues The Lancet Oncology ·Paresh Vyas Hit paper breakdown →	2001	697
2	Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia Science Translational Medicine ·Max Jan, Thomas M. Snyder, M. Ryan Corces, Paresh Vyas, Irving L. Weissman, Stephen R. Quake, Ravindra Majeti Hit paper breakdown →	2012	525
3	Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML) Blood ·Oliver Goodyear, Mike Dennis, Nadira Jilani, Justin Loke, Shamyla Siddique, Gordon B. Ryan, Jane Nunnick, Rahela Khanum, Manoj Raghavan, Mark Cook, John A. Snowden, Mike Griffiths, Nigel H. Russell, John Yin, Charles Crawley, Gordon Cook, Paresh Vyas, Paul Moss, Ram Malladi, Charles Craddock	2012	304
4	Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia Nature Medicine ·Alice Giustacchini, Supat Thongjuea, Nikolaos Barkas, Petter Woll, Benjamin Povinelli, Christopher A.G. Booth, Paul Sopp, Ruggiero Norfo, Alba Rodríguez-Meira, Neil Ashley, Lauren E. Jamieson, Paresh Vyas, Kristina Anderson, Åsa Segerstolpe, Hong Qian, Ulla Olsson‐Strömberg, Satu Mustjoki, Rickard Sandberg, Sten Eirik W. Jacobsen, Adam J. Mead	2017	292
5	Consequences of GATA-1 Deficiency in Megakaryocytes and Platelets Blood ·Paresh Vyas, Kenneth A. Ault, Carl W. Jackson, Stuart H. Orkin, Ramesh A. Shivdasani	1999	268
6	Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia Blood ·Oliver Goodyear, Angelo Agathanggelou, Igor Novitzky‐Basso, Shamyla Siddique, Tina McSkeane, Gordon B. Ryan, Paresh Vyas, Jamie Cavenagh, (unknown), Paul Moss, Charles Craddock	2010	266
7	The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase. Proceedings of the National Academy of Sciences ·Ashok R. Amin, Paresh Vyas, Mukundan Attur, J Leszczynska-Piziak, I R Patel, Gerald Weissmann, Steven B. Abramson	1995	266
8	Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment Blood ·Francis Mussai, Carmela De Santo, Issa Abu‐Dayyeh, Sarah Booth, Lynn Quek, Rosanna M. McEwen-Smith, Amrana Qureshi, Francesco Dazzi, Paresh Vyas, Vincenzo Cerundolo	2013	264
9	Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response Blood ·Michael Amatangelo, Lynn Quek, Alan H. Shih, Eytan M. Stein, Mikhail Roshal, Muriel D. David, Benoît Marteyn, Noushin Farnoud, Stéphane de Botton, Olivier Bernard, Bin Wu, Katharine Yen, Martin S. Tallman, Elli Papaemmanuil, Virginie Penard‐Lacronique, Anjan Thakurta, Paresh Vyas, Ross L. Levine	2017	251
10	GATA‐1 forms distinct activating and repressive complexes in erythroid cells The EMBO Journal ·Patrick Rodriguez, Edgar Bonte, Jeroen Krijgsveld, Katarzyna E. Kolodziej, Boris Guyot, Albert J. R. Heck, Paresh Vyas, Ernie de Boer, Frank Grosveld, John Strouboulis	2005	227
11	The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for up-regulated neuronal nitric oxide synthase. The Journal of Experimental Medicine ·A. R. Amin, Paul E. Di Cesare, Paresh Vyas, Mukundan Attur, Edith Tzeng, Timothy R. Billiar, Steven A. Stuchin, Steven B. Abramson	1995	206
12	The First-in-Class Anti-CD47 Antibody Magrolimab (5F9) in Combination with Azacitidine Is Effective in MDS and AML Patients: Ongoing Phase 1b Results Blood ·David A. Sallman, Adam S. Asch, Monzr M. Al Malki, Daniel J. Lee, William B. Donnellan, Guido Marcucci, Suman Kambhampati, Naval Daver, Guillermo Garcia‐Manero, Rami S. Komrokji, Joanna Van Elk, Ming Lin, Jens-Peter Volkmer, Chris H. Takimoto, Mark P. Chao, Paresh Vyas	2019	167
13	Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes Nature Communications ·Moritz Gerstung, Andrea Pellagatti, Luca Malcovati, Aristoteles Giagounidis, Matteo Giovanni Della Porta, Martin Jädersten, Hamid Dolatshad, Amit Verma, Nicholas C.P. Cross, Paresh Vyas, Sally Killick, Eva Hellström‐Lindberg, Mario Cazzola, Elli Papaemmanuil, Peter J. Campbell, Jacqueline Boultwood	2015	148
14	Single-cell analysis reveals the continuum of human lympho-myeloid progenitor cells Nature Immunology ·Dimitris Karamitros, Bilyana Stoilova, Zahra Aboukhalil, Fiona Hamey, Andreas Reinisch, Marina Samitsch, Lynn Quek, Georg Otto, Emmanouela Repapi, Jessica Doondeea, Batchimeg Usukhbayar, Julien Calvo, Stephen Taylor, Nicolas Goardon, Emmanuelle Six, Françoise Pflumio, Catherine Porcher, Ravindra Majeti, Berthold Göttgens, Paresh Vyas	2017	148
15	Genome-wide identification of TAL1's functional targets: Insights into its mechanisms of action in primary erythroid cells Genome Research ·Mira Kassouf, Jim R. Hughes, Stephen Taylor, Simon J. McGowan, Shamit Soneji, Angela L. Green, Paresh Vyas, Catherine Porcher	2010	143
16	Cis-acting sequences regulating expression of the human α-globin cluster lie within constitutively open chromatin Cell ·Paresh Vyas, Mark A. Vickers, David L. Simmons, Helena Ayyub, Charles Craddock, Douglas R. Higgs	1992	141
17	Mice Lacking Transcription Factor NF-E2 Provide In Vivo Validation of the Proplatelet Model of Thrombocytopoiesis and Show a Platelet Production Defect That Is Intrinsic to Megakaryocytes Blood ·Patrick Lécine, Jean‐Luc Villeval, Paresh Vyas, Bethany Swencki, Yuhui Xu, Ramesh A. Shivdasani	1998	138
18	Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): a single-arm, phase 1b and randomised, phase 2 trial The Lancet Oncology ·Courtney D. DiNardo, Andre C. Schuh, Eytan M. Stein, Pau Montesinos, Andrew H. Wei, Stéphane de Botton, Amer M. Zeidan, Amir T. Fathi, Hagop M. Kantarjian, John M. Bennett, Mark G. Frattini, Patricia Martin‐Regueira, Frederik Lersch, Jing Gong, Maroof Hasan, Paresh Vyas, Hartmut Döhner	2021	135
19	Identification of distinct molecular phenotypes in acute megakaryoblastic leukemia by gene expression profiling Proceedings of the National Academy of Sciences ·Jean‐Pierre Bourquin, Aravind Subramanian, Claudia Langebrake, Dirk Reinhardt, Olivier Bernard, Paola Ballerini, André Baruchel, Hélène Cavé, Nicole Dastugue, Henrik Hasle, Gertjan J.L. Kaspers, Michel Lessard, Lucienne Michaux, Paresh Vyas, Elisabeth van Wering, C. Michel Zwaan, Todd R. Golub, Stuart H. Orkin	2006	133
20	Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial Biology of Blood and Marrow Transplantation ·Charles Craddock, Nadira Jilani, Shamyla Siddique, Christina Yap, Josephine Khan, Sandeep Nagra, (unknown), Paul Ferguson, Peter Hazlewood, Richard J. Buka, Paresh Vyas, Oliver Goodyear, Eleni Tholouli, Charles Crawley, Nigel H. Russell, Jenny Byrne, Ram Malladi, John A. Snowden, Mike Dennis	2015	130

About Paresh Vyas

Paresh Vyas is a scholar working on Hematology, Molecular Biology, Genetics, Immunology and Public Health, Environmental and Occupational Health, having authored 235 papers that have together received 9.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (147 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (34 papers), Chronic Myeloid Leukemia Treatments (32 papers), Epigenetics and DNA Methylation (22 papers), Multiple Myeloma Research and Treatments (22 papers), Hemoglobinopathies and Related Disorders (20 papers), Acute Lymphoblastic Leukemia research (19 papers) and Protein Degradation and Inhibitors (19 papers). The work is most often cited by research in Hematology (4.9k citations), Genetics (1.7k citations), Immunology (1.6k citations), Molecular Biology (4.2k citations) and Cancer Research (811 citations). Paresh Vyas has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Stuart H. Orkin, Charles Craddock, Catherine Porcher, Irene Roberts, Ramesh A. Shivdasani, Ravindra Majeti, Carl W. Jackson, Kenneth A. Ault, Douglas R. Higgs and Irving L. Weissman. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Haematologica and HemaSphere.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Paresh Vyas

Impact in

Papers in i

In The Last Decade

Paresh Vyas

Paresh Vyas's Hit Papers

Peers

Countries citing papers authored by Paresh Vyas

Fields of papers citing papers by Paresh Vyas

All Works

About Paresh Vyas

Explore authors with similar magnitude of impact

Papers in